Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

PFE 34.26 +0.11 (0.32%)
price chart
Goodbye, Lipitor. Pfizer Bids a Farewell
Pfizer officials told The Wall Street Journal that the company is no longer negotiating new contracts to sell Lipitor to health plans, which are signing up to sell generic versions at far lower prices.
Merck, Pfizer Back Lawmakers Who Oppose Company Products
In addition to Johnson & Johnson, Phrma members Pfizer Inc., Bayer AG, and Merck & Co. Inc. sell birth-control products such as estrogen, IUDs or so-called morning after pills known as Plan B, according to IMS Health, a health-care information and ...
Pfizer Recalls 650000 Bottles of Advil Liqui-Gels
Pfizer Inc. recalled 650,000 units of Advil Liqui-Gels in March because of an odor caused by over-processed gelatin. The pills were recalled from stores by distributors in a March 16 letter sent by New York-based Pfizer, according to the U.S.
Report: Pfizer voluntarily recalled 650000 bottles of Advil Liqui-Gels  Michigan Business Review - MLive.com
Pfizer announces results from Lyrica clinical studies on fibromyalgia
Pfizer Inc. (NYSE: PFE) announced the results of studies on Lyrica� (pregabalin) capsules CV presented at the American Pain Society Annual Meeting in Honolulu.
Pfizer Gets Support For Arthritis Drug Approval
Pfizer Inc. (NYSE:PFE) has moved one step closer to approval of a drug that will improve options in the treatment of Rheumatoid Arthritis.
Apple, Google, Oracle, AstraZeneca: Intellectual Property
Novartis, Pfizer's Wyeth Seek Delay in Hemophilia Patents Case. The diagnostics unit of Novartis AG and Pfizer Inc.'s Wyeth filed a joint motion on May 14 to stay the deadlines in a drug-patent trial scheduled to begin June 4 in Texas, saying that the ...
Mylan Denied Invalidity In Cancer Drug IP Battle
Law360, New York (May 2, 2012, 5:42 PM EDT) -- A Delaware federal judge Tuesday found in favor of Genentech Inc., Pfizer Inc. and Astellas Pharma Inc. unit OSI Pharmaceuticals Inc. in their patent infringement suit against Mylan Pharmaceuticals Inc ...
Google's Brin Makes Strides in Hunt for Parkinson's Cure
The advances are encouraging Pfizer Inc. and GlaxoSmithKline Plc to pursue a new class of medicines that may become the first to slow the progress of Parkinson's disease in a unique collaboration that Brin is funding.
Personalized Rx for Children
In 2010 a Pfizer-sponsored study showed it shrank or stabilized tumors in 90% of 82 patients whose tumors had an aberration in the ALK gene.
PPD names new CEO
Pfizer Inc. executive David Simmons has been named chairman and CEO of PPD, the Wilmington-based company said Wednesday. Simmons is the first CEO named by the clinical research company since it was taken private in December by The Carlyle ...
PPD names Pfizer executive David Simmons its new CEO  MedCity News